Treatment of muscle-invasive bladder cancer in Canada: A survey of genitourinary medical oncologists and urologists

INTRODUCTION: Uptake of neoadjuvant chemotherapy (NC) for muscle invasive bladder cancer (MIBC) has been low despite evidence of a survival benefit. The primary aim of this study was to better understand why the rates are low and determine what factors specifically influence the decision to recommen...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hsu, Tina, Black, Peter C., Chi, Kim N., Canil, Christina M., Eigl, Bernhard J., Kulkarni, Girish, North, Scott, Wood, Lori, Zlotta, Alexandre R., Lau, Anthea, Panzarella, Tony, Sridhar, Srikala S.
Formato: Artigo
Idioma:Inglês
Publicado: Canadian Medical Association 2014
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4216285/
https://ncbi.nlm.nih.gov/pubmed/25408794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.2111
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares